Clinical Trial: Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional




Official Title: High Dose Erythropoietin for Neonates With Asphyxia

Brief Summary: Erythropoietin (Epo) is a hormone normally found in the body that may protect brain cells from damage due to lack of oxygen. This study will evaluate the safety of high-dose Epo in infants who did not get enough oxygen during birth.